Metabolic Management of insulin resistance and diabesity Filomena Trindade, MD, MPH Effect of Dietary Lipids on the Gut Microbiome: What Do We Know? Angela Zivkovic, PhD Aspirin Effectiveness and its Influence on Cardiovascular Risk Jeffrey Boone, M.D. The Microbiome and Cardiovascular Disease Thomas Sult, MD Pharmacological Principles of Treating Type 1 Diabetes Mellitus Blair Geho, MD, PhD The Human Microbiome in Health and Disease Robert Rountree, MD Tame the Flames of PCOS: A Unique Integrative Approach Felice Gersh, MD Why We Get Fat?: An Alternative Hypothesis of Obesity Gary Taubes « Page 1 » CME Webcasts Racial/Ethnic Disparities in Cardiovascular Outcomes Aggressive Detection and Reversal of Heart Disease Identifying Subclinical Cardiovascular Disease The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia Genetic testing in cardiovascular disease News You Can Use United States Preventive Services Task Force Recommends Increased Testing for Diabetes Are Revolutionary New Drugs on the Horizon to Reduce CV Risks? A New Role for hsCRP? Study Reveals Value of Galectin-3 and NT-proBNP in Predicting Heart Failure and Death Are Lipid Targets Back?
